A randomised double-blind placebo-controlled trial of aspirin in primary prevention of CVD events or dementia in the aged ID: 334047

  • McNeil, John (Primary Chief Investigator (PCI))
  • Beilin, Lawrence J. (Chief Investigator (CI))
  • Krum, Henry (Chief Investigator (CI))
  • Nelson, Mark (Chief Investigator (CI))
  • Reid, Christopher (Chief Investigator (CI))
  • Tonkin, Andrew (Chief Investigator (CI))

Project: Research

Project Details

Effective start/end date1/01/0531/12/09


  • National Health and Medical Research Council (NHMRC) (Australia): A$3,503,500.00